The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development. The 14th Annual PD Therapeutics Conference is scheduled to be held on October 13, 2022, in-person, in New York.
Each year, the PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.
REGISTER HERE (Registration closes Tuesday, October 11 at 5 P.M. EST)
For Questions or Updates,
Please contact firstname.lastname@example.org.
Sohini Chowdhury, Deputy CEO |The Michael J. Fox Foundation
Brian Fiske, PhD, Co-Chief Scientific Officer | The Michael J. Fox Foundation
Roland Staal, PhD, Director of Pharmacology | Lucy Therapeutics
Arthur A. Simen, MD, PhD, Executive Medical Director | Takeda Development Center Americas
Kenneth Marek, MD, President | Institute for Neurodegenerative Disorders
Stacie Weninger, PhD, President | FBRI
Kevin McFarthing, PhD | Research Advocate
Mark Frasier, PhD, Co-Chief Scientific Officer | The Michael J. Fox Foundation
Lana Chahine, MD, Assistant Professor of Neurology | University of Pittsburgh
John Seibyl, MD, Co-Founder & Chairman | Institute for Neurodegenerative Disorders
Josh Cosman, Director, Digital Health Strategy | AbbVie
Glenn Stebbins, PhD, Professor Emeritus | Rush University Medical Center
Tanya Simuni, MD | Arthur C. Nielsen Jr. Professor of Neurology | Director, Parkinson’s Disease and Movement Disorders Center | Northwestern University Feinberg School of Medicine
Catherine Kopil, PhD, Senior Vice President | The Michael J. Fox Foundation
Shalini Padmanabhan, PhD, Vice President | The Michael J. Fox Foundation
Fiona Elwood, PhD, Vice President Neurodegeneration Disease Area Stronghold Leader | Janssen Pharmaceuticals
Nicholas Wood, MbChB, PhD, FRCP, FMedSci | UCL Queen Square Institute of Neurology
Manuela Polydoro, PhD, Head of Translational Medicine | Muna Therapeutics
Jim Sullivan, PhD, Co-Founder & CEO| Vanqua Bio, Venture Partner, OrbiMed
Jimmy Choi | Patient Council Member, The Michael J. Fox Foundation
Identification and Evaluation of Novel Imaging Probes for Alpha Synuclein Aggregates by DNA-Encoded Library Screening
Changning Wang, PhD
Assistant Professor of Radiology
Athinoula A. Martinos Center for Biomedical Imaging
Massachusetts General Hospitals
Harvard Medical School
Imaging Studies in Parkin Patients and Advancement of Parkin Gene Therapy
Jennifer A. Johnston
Advancing TRPML1 Agonists for GBA-PD
Magdalene Moran, PhD
President & Chief Scientific Officer
Associations of Reduced Caffeine Exposure with PD and Reduced GCase Activity with GBA Carrier Status: A Metabolomic Biomarker Study in PPMI Plasma
Sarah Huntwork- Rodriguez, PhD
Director, Senior Scientist, Translational Sciences
Small Molecule PINK1 Activators Rescue Parkinson’s Disease Pathology
Nicholas Hertz, PhD
Chief Scientific Officer & Co-Founder
Ultrasensitive 24h- Semi-Quantitative Seed Amplification Assay for the Accurate Differentiation between MSA and LBD
Luis Concha, PhD
Director of Research & Development
Interested in Sponsorship Opportunities?
Contact our Research Alliances team at email@example.com for information about 2022 sponsorship opportunities.
Convene at 117 West 46th Street is our largest event venue in Midtown West Manhattan. Located between Times Square and Rockefeller Center, it’s the ideal space (up to 600 guests) for your next summit, awards dinner, town hall, or gala. As one of Convene's flagship properties, this space offers "white-box" design capability. Professional meeting planners are provided with the ability to customize the space with multiple sponsor and corporate branding opportunities with our digital video walls, physical exhibit areas, columns, and walls.
*Please note that Convene requires all attendees and staff to be fully vaccinated against COVID-19 in order to attend a meeting at their facility. You will be required to show proof of vaccination status at the door.